Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious disease
Biotech
Evaxion halts infectious disease work in R&D refocus on oncology
The Danish biotech will seek partnerships to take its infectious disease and autoimmune programs forward.
Marissa Russo
Nov 19, 2026 10:02am
Lilly pens deal with Gateway Labs resident for RNA vax platform
Aug 20, 2026 10:45am
Cash-strapped Alopexx reignites plans to go public via $30M IPO
Jun 27, 2026 8:16am
Lilly inks deals to buy 3 vaccine developers for up to $3.8B
May 26, 2026 7:57am
Altai Capital angles for OraSure board seats and a sale
Mar 17, 2026 12:40pm
ARPA-H director eyes future beyond vaccines
Jan 20, 2026 5:00am